BD Launches Incada™ Platform to Revolutionize Healthcare Data Integration and Delivery
- Becton Dickinson launched the BD Incada™ Connected Care Platform to enhance data integration across medical devices.
- The platform utilizes AI-driven analytics for real-time insights and improves decision-making in healthcare settings.
- BD's innovations aim to transform healthcare delivery and expand access to critical diagnostic services globally.
BD's Revolutionary Incada™ Connected Care Platform Transforms Healthcare Delivery
Becton, Dickinson and Company (BD) has launched the BD Incada™ Connected Care Platform, a groundbreaking, AI-driven, cloud-based system designed to enhance data integration across its medical devices. This innovative platform, unveiled on October 20, 2025, aims to create a cohesive ecosystem by connecting a wide range of devices, including infusion pumps, patient monitors, and pharmacy robotics. Bilal Muhsin, Executive Vice President and President of BD Connected Care, highlights that the platform seeks to advance beyond traditional connectivity approaches by establishing meaningful links among various medical technologies. This strategic move illustrates BD's commitment to leveraging its extensive portfolio to deliver transformative benefits to healthcare providers.
The BD Incada™ Platform, built on Amazon Web Services’ robust cloud infrastructure, is equipped to manage data generated by nearly three million smart, connected BD devices. Among its key features is enterprise-wide visibility into medication inventory, allowing clinicians to identify patterns, ensure medication availability, minimize waste, and enhance labor efficiency. The platform's AI-driven analytics enable users to pose natural language questions for real-time insights, while customizable dashboards empower clinical teams to act swiftly based on findings. These capabilities mark a significant advancement in BD’s Connected Care strategy, ultimately aiming to improve decision-making and operational efficiency in medical settings.
Moreover, the BD Incada™ Platform offers flexible and secure storage solutions, ensuring timely medication delivery to patients. By integrating data from various devices into a single platform, BD positions itself at the forefront of healthcare technology innovation. This initiative not only enhances data connectivity but also aims to transform the way healthcare providers manage and utilize information, fostering improved patient outcomes and operational efficiencies across the industry.
In addition to the Connected Care initiative, BD has also introduced a self-collection solution for HPV testing targeting markets outside the United States. This innovative approach allows for at-home sample collection and automates laboratory processing using the advanced BD COR™ System. The system has been certified under the In Vitro Diagnostic Medical Device Regulation (IVDR) in Europe and is expected to significantly improve access to cervical cancer screening. By facilitating safe, simple, and non-invasive sample collection, BD continues to enhance laboratory efficiency while ensuring specimen integrity throughout the testing process.
Related Cashu News

Merit Medical Systems Launches Employee Stock Ownership Plan to Boost Engagement and Stability
Merit Medical Systems (Ticker: MMSI) recently takes a significant step in enhancing its employee engagement and ownership structure with the launch of a new Employee Stock Ownership Plan (ESOP). The c…

Brookdale Senior Living launches second season of educational podcast "The Grey Take.
Brookdale Senior Living (Ticker: BKD) launches the second season of its popular podcast, "The Grey Take," which serves as a valuable resource for families exploring senior living options. The podcast…

Molina Healthcare Gains Momentum with Increased Risk Adjustment Payments and Positive Revenue Outlook
Molina Healthcare (Ticker: MOH) is making significant strides in its revenue outlook due to recently released risk adjustment figures from the Centers for Medicare & Medicaid Services (CMS). These upd…

Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices
Align Technology Inc. (Ticker: ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a co…

